Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on AMGN
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
- Dividends
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Amgen, Inc. (NQ:AMGN)
Delayed:
104.24
--0 (-0%)
Trade Now!
Previous Close
$104.24
52 Week High
$114.95
Open
$2550.62
52 Week Low
$67.61
Day High
$104.24
P/E
17.64
Day Low
$104.24
EPS
$5.91
Volume
500
Friends, Peers and Foes
(?)
:
BIIB
,
BMY
,
ABT
,
RBCC
,
NPSP
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 21, 2013 08:19 PM
Form 4 AMGEN INC For: May 21 Filed by: Balachandran Madhavan
May 21, 2013 05:00 AM
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 20, 2013 07:16 PM
Form 4 AMGEN INC For: May 17 Filed by: HENDERSON REBECCA M
May 17, 2013 05:42 PM
Form 4 AMGEN INC For: May 16 Filed by: Patton Cynthia M
May 16, 2013 05:43 PM
Form 4 AMGEN INC For: May 14 Filed by: PELHAM JUDITH C
May 16, 2013 05:39 PM
Form 4 AMGEN INC For: May 14 Filed by: BIONDI FRANK
May 16, 2013 04:18 PM
Amgen To Present At The UBS Global Life Sciences Conference
May 16, 2013 07:00 AM
Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
May 15, 2013 06:03 PM
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013 06:00 PM
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
View All Articles
Apr 23, 2013 04:03 PM
Amgen, Inc. (AMGN) Tops Q1 EPS by 12c, Sales Light; Sees FY EPS Above Midpoint
Feb 7, 2013 07:49 AM
Amgen (AMGN) Will Update on Long-Term Outlook; Guides FY13 EPS Above Views
Jan 23, 2013 04:03 PM
Amgen, Inc. (AMGN) Tops Q4 EPS by 1c
Oct 23, 2012 04:05 PM
Amgen, Inc. (AMGN) Tops Q3 EPS by 20c; Boosts FY12 Outlook
Jul 26, 2012 04:06 PM
Amgen, Inc. (AMGN) Tops Q2 EPS by 29c
Apr 24, 2012 04:04 PM
Amgen, Inc. (AMGN) Tops Q1 EPS by 16c
Jan 26, 2012 04:02 PM
Amgen, Inc. (AMGN) Misses Q4 EPS by 1c; Guides FY12 EPS
Oct 24, 2011 04:07 PM
Amgen, Inc. (AMGN) Posts Solid Q3 Results; Boosts Buyback to $10B; Raises FY11 EPS Guidance
Jul 29, 2011 08:02 AM
Amgen (AMGN) Tops Q2 EPS by 9c; Sees FY11 at Upper End of Guidance Range; Declares First-Ever Dividend
View All Major News
May 6, 2013 07:14 AM
Amgen (AMGN), Transgenomic Enter CE-IVD Test Development Agreement
May 3, 2013 03:43 PM
UPDATE: Monkeys Treated with Amgen (AMGN) Drugs More Likely to Survive Nuclear Attack; FDA Approves Use
May 1, 2013 11:16 AM
Notable Analyst Rating Changes 05/01: (AMGN) (MSPD) (ULTI) Upgraded; (LSI) (OIS) (OKE) Downgraded
May 1, 2013 09:35 AM
StreetInsider.com Pre-Open Movers 5/1: (IQNT) (MSPD) (RATE) Higher; (HIMX) (MELA) (MRK) Lower (more...)
May 1, 2013 07:20 AM
Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List
May 1, 2013 06:45 AM
Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy
Apr 24, 2013 12:24 PM
Amgen (AMGN) EPS Growth is 'Healthy', Target Raised - Jefferies
Apr 24, 2013 09:36 AM
StreetInsider.com Pre-Open Movers 4/24: (BKI) (IRBT) (YUM) Higher; (VOCS) (EW) (AAPL) Lower (more...)
Apr 24, 2013 06:40 AM
Piper Jaffray Downgrades Amgen (AMGN) to Neutral
Apr 23, 2013 06:25 PM
Streetinsider.com After-Hours Movers 4/23: (IRBT) (YUM) (MSFT) (BRCM) Higher; (DV) (AWAY) (JNPR) Lower (more...)
View All Reports
May 21, 2013 05:00 AM
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 16, 2013 04:18 PM
Amgen To Present At The UBS Global Life Sciences Conference
May 16, 2013 07:00 AM
Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
May 15, 2013 06:03 PM
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013 06:00 PM
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
May 13, 2013 05:00 AM
RBCC Partner n3D Signs U.S. Distribution Agreement
May 9, 2013 04:08 PM
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 7, 2013 04:05 PM
Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
May 6, 2013 07:00 AM
Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer
May 6, 2013 05:00 AM
World’s Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D
View All Press Releases
May 21, 2013 08:19 PM
Form 4 AMGEN INC For: May 21 Filed by: Balachandran Madhavan
May 20, 2013 07:16 PM
Form 4 AMGEN INC For: May 17 Filed by: HENDERSON REBECCA M
May 17, 2013 05:42 PM
Form 4 AMGEN INC For: May 16 Filed by: Patton Cynthia M
May 16, 2013 05:43 PM
Form 4 AMGEN INC For: May 14 Filed by: PELHAM JUDITH C
May 16, 2013 05:39 PM
Form 4 AMGEN INC For: May 14 Filed by: BIONDI FRANK
May 6, 2013 05:28 PM
Form 4 AMGEN INC For: May 02 Filed by: Harper Sean E
May 3, 2013 04:24 PM
Form 10-Q AMGEN INC For: Mar 31
May 3, 2013 01:45 PM
Form SC 13G/A AMGEN INC Filed by: PRIMECAP MANAGEMENT CO/CA/
May 2, 2013 06:27 PM
Form 4 AMGEN INC For: Apr 30 Filed by: de Carbonnel Francois
Apr 30, 2013 06:12 PM
Form 4 AMGEN INC For: Apr 26 Filed by: SUGAR RONALD D
View All Filings
Entities mentioned with
AMGN
Earnings
|
View Related Stories »
Citi
|
View Related Stories »
Bank of America
|
View Related Stories »
UBS
|
View Related Stories »
JPMorgan
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Dividend
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Options
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Barclays
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Robert W Baird
|
View Related Stories »
Goldman Sachs Conviction Buy List
|
View Related Stories »
Goldman Sachs
|
View Related Stories »
Trading Radar
|
View Related Stories »
Crude Oil
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
David Moenning
|
View Related Stories »
Needham & Company
|
View Related Stories »
Argus
|
View Related Stories »
Stock Buyback
|
View Related Stories »
Show More...
View All Entities